Wikidata

(Q40731233)

English

A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days

scientific article published on August 1, 1992

In more languages
default for all languages
No label defined

No description defined

Statements

title
A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days (English)
reason for preferred rank
most precise value
1 reference
stated in
Europe PubMed Central
PubMed publication ID
1330081
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1330081
retrieved
14 September 2022
A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days (English)
1 reference
stated in
National Center for Biotechnology Information
PubMed publication ID
1330081
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1330081
retrieved
14 September 2022
author name string
Kneuper-Hall R
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
1330081
retrieved
23 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40731233&oldid=2144528559"